Literature DB >> 27583586

Effect of inflammatory mediators on cardiovascular function.

Ursula Müller-Werdan1, Roland Prondzinsky, Karl Werdan.   

Abstract

PURPOSE OF REVIEW: Inflammatory mediators can interfere with cardiovascular system. This article describes some recent findings in this field. RECENT
FINDINGS: In septic cardiomyopathy, direct and indirect interactions of endotoxin with the pacemaker current contribute to cardiac autonomic dysfunction and inadequately high heart rate, worsening prognosis. In myocardial infarction, inflammatory blood cells correlate with impaired coronary microvascular reperfusion. In cardiogenic shock, systemic inflammation and development of multiorgan dysfunction syndrome have a major impact on mortality. Shock patients have low levels of activated protein C and high levels of the endogenous danger signal molecule peroxiredoxin 1; both conditions might represent further therapeutic targets. As major cause of cytopathic hypoxia, mitochondrial dysfunction has also been identified in mitochondria from peripheral blood mononuclear cells in paediatric septic shock. Transcatheter aortic valve endocarditis, a new endocarditis entity after transcatheter aortic valve implantation in old and very old patients, needs our special attention, because immunosenescence may modify the clinical course in a negative sense. Systemic spreading of endocarditis to septic shock adds to the local valve infection the problem of septic shock.
SUMMARY: Not only in septic shock, but also in classic heart diseases like cardiogenic shock and endocarditis, the detrimental role of inflammatory mediators becomes more and more evident, whereas effective anti-inflammatory treatment concepts are still missing.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27583586     DOI: 10.1097/MCC.0000000000000345

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  7 in total

1.  Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction.

Authors:  Francesca Zimetti; Stefano De Vuono; Monica Gomaraschi; Maria Pia Adorni; Elda Favari; Nicoletta Ronda; Maria Anastasia Ricci; Fabrizio Veglia; Laura Calabresi; Graziana Lupattelli
Journal:  J Lipid Res       Date:  2017-08-22       Impact factor: 5.922

2.  Sufentanil ameliorates oxygen-glucose deprivation/reoxygenation-induced endothelial barrier dysfunction in HCMECs via the PI3K/Akt signaling pathway.

Authors:  Lianggang Wang; Chunlin Ge; Xinxin Zhang
Journal:  Exp Ther Med       Date:  2022-05-11       Impact factor: 2.751

Review 3.  Susceptibility to COVID-19 in populations with health disparities: Posited involvement of mitochondrial disorder, socioeconomic stress, and pollutants.

Authors:  Yunyi Yao; David A Lawrence
Journal:  J Biochem Mol Toxicol       Date:  2020-09-09       Impact factor: 3.568

4.  MicroRNA-155 attenuates late sepsis-induced cardiac dysfunction through JNK and β-arrestin 2.

Authors:  Yu Zhou; Yan Song; Zahir Shaikh; Hui Li; Haiju Zhang; Yi Caudle; Shouhua Zheng; Hui Yan; Dan Hu; Charles Stuart; Deling Yin
Journal:  Oncotarget       Date:  2017-07-18

5.  Formation of a TBX20-CASZ1 protein complex is protective against dilated cardiomyopathy and critical for cardiac homeostasis.

Authors:  Leslie Kennedy; Erin Kaltenbrun; Todd M Greco; Brenda Temple; Laura E Herring; Ileana M Cristea; Frank L Conlon
Journal:  PLoS Genet       Date:  2017-09-25       Impact factor: 5.917

6.  NCF2, MYO1F, S1PR4, and FCN1 as potential noninvasive diagnostic biomarkers in patients with obstructive coronary artery: A weighted gene co-expression network analysis.

Authors:  Xian-Gang Mo; Wei Liu; Yao Yang; Saber Imani; Shan Lu; Guorong Dan; Xuqiang Nie; Jun Yan; Rixing Zhan; Xiaohui Li; Youcai Deng; Bingbo Chen; Yue Cai
Journal:  J Cell Biochem       Date:  2019-06-27       Impact factor: 4.429

7.  Effects of ZIF-8 MOFs on structure and function of blood components.

Authors:  Jiansheng Lin; Linghong Huang; Haibo Ou; An Chen; Rong Xiang; Zonghua Liu
Journal:  RSC Adv       Date:  2021-06-16       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.